Home/Filings/4/0001209191-22-060218
4//SEC Filing

Monohon Ted 4

Accession 0001209191-22-060218

CIK 0001662774other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 5:37 PM ET

Size

5.0 KB

Accession

0001209191-22-060218

Insider Transaction Report

Form 4
Period: 2022-12-05
Monohon Ted
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2022-12-05$0.72/sh1,640$1,18129,311 total
Footnotes (1)
  • [F1]Represents shares sold to satisfy tax withholding obligations that arose in connection with the vesting of 4,250 shares of Restricted Stock Units granted on March 3, 2022. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2022.

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1
  • filerCIK 0001606905

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:37 PM ET
Size
5.0 KB